Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1365 |
---|---|
Product Name | Anti-Human IL31RA Recombinant Antibody |
Molecular Name | Nemolizumab |
Alias | Anti-IL31RA Recombinant Antibody, Research Grade Nemolizumab |
CAS Number | 1476039-58-3 |
Target | IL31RA[Homo sapiens] |
Isotype | IgG2 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, IHC, FCM, IP, IF, FuncS |
Buffer | PBS, pH7.5 |
Background | Nemolizumab is an experimental drug for the treatment of itching in people with atopic dermatitis. It is a monoclonal antibody that blocks the interleukin-31 receptor A. Results of a Phase II clinical trial were published in March 2017. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |